Список проголосовавших за комментарий " On The Wires<ul><li>Sarepta Therapeutics (<strong>SRPT</strong>) provided an update to investors that it will present data from eteplirsen studies at the MDA Scientific Conference in Arlington, Virginia on March 19-22. Sarepta is scheduled to give an oral, as well as poster presentation, on the cardiac function of eteplirsen-treated patients; a poster presentation on non-ambulatory patients; and a poster presentation on the pulmonary function of eteplirsen-treated patients.</li><li>Boehringer Ingelheim and Eli Lilly and Company (<strong>LLY</strong>) announced that the EMPEROR HF clinical trial program was initiated. EMPEROR HF comprises two phase III outcome studies that will investigate empagliflozin for the treatment of adults with chronic heart failure. The trials will involve not only adults with type 2 diabetes who have heart failure, but also heart failure patients who do not have diabetes.</li><li>Fiat Chrysler Automobiles N.V. (<strong>FCAU</strong>) announced that it has successfully completed the placement of 15,948,275 common shares of CNH Industrial N.V. (CNHI), representing 1.17% of CNHI's common shares. The total consideration of the Placement amounted to 144.3 mln euro. The Placement, carried out through an accelerated bookbuilding procedure directed to certain institutional investors, was priced at 9.05 euro per share. Following the settlement of the sale, FCA holds no residual shares in CNHI.</li><li>JinkoSolar Holding (<strong>JKS</strong>) announced that its wholly owned subsidiary, JinkoSolar, will partner with CleanFund Commercial PACE Capital to offer long-term project financing to US commercial project customers through the SolarPACE program.</li><li>Alaska Communications Systems Group (<strong>ALSK</strong>) announced a tender offer to purchase any and all of its outstanding 6.25% Convertible Notes due 2018. As of March 17, 2017, there were $94.0 mln aggregate principal amount of the Notes outstanding. Upon the terms and subject to the conditions set forth in the Company's Offer to Purchase, dated March 17, 2017, and the related Letter of Transmittal, the Company is offering to pay, for cash, an amount equal to $1,025 per $1,000 principal amount of Notes purchased. The Tender Offer will expire at 12:00 AM ET, on April 14, 2017, or any other date and time to which the Company extends such Tender Offer, unless earlier terminated.</li><li>Huntsman Corporation (<strong>HUN</strong>) announced a plan to close the white end finishing and packaging operation of its titanium dioxide (TiO2) manufacturing facility based in Calais, France, during the third quarter 2017. The announced plan follows the 2015 closure of the black end manufacturing operations and would result in the closure of the entire facility. 108 positions on the site will be affected. The plan to close the Calais white end is structured to allow completion of any remaining obligations to any third parties and regulators.</li></ul>"